Currently out of the existing stock ratings of Richard Vosser, 37 are a BUY (44.05%), 29 are a HOLD (34.52%), 18 are a SELL (21.43%).

Richard Vosser

Work Performance Price Targets & Ratings Chart

Analyst Richard Vosser, currently employed at JPMORGAN, carries an average stock price target met ratio of 51.33% that have a potential upside of 23.01% achieved within 313 days. Previously, Richard Vosser worked at MORGAN STANLEY.

Richard Vosser’s has documented 145 price targets and ratings displayed on 11 stocks. The coverage is on Healthcare, Consumer Cyclical sectors.

Most recent stock forecast was given on NVO, Novo Nordisk A/S at 24-Feb-2026.

Wall Street Analyst Richard Vosser

Analyst best performing recommendations are on RH (RH).
The best stock recommendation documented was for RH (RH) at 1/3/2023. The price target of $294.29 was fulfilled within 6 days with a profit of $41.01 (16.19%) receiving and performance score of 26.99.

Average potential price target upside

of $142.76 (25.5%) on RH (RH).
of $64.05 (129.72%) on UCBJY (UCB SA ADR).
of $16.74 (24.29%) on NVS (NOVARTIS AG ADR).

NVO Novo Nordisk A/S NVS Novartis AG ADR SNY Sanofi ADR RHHBY Roche Holding Ltd ADR UCBJY UCB SA ADR MOLN Molecular Partners AG ADR MOR MorphoSys AG ADR GSK GlaxoSmithKline PLC ADR IP International Paper LZ LegalZoom.com RH RH

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

James Quigley (GOLDMAN SACHS)